Molina Healthcare price target lowered to $430 from $437 at Barclays

Barclays analyst Andrew Mok lowered the firm’s price target on Molina Healthcare to $430 from $437 and keeps an Equal Weight rating on the shares. The company reported a Q1 beat on revenue and membership, but the 2024 guidance was maintained on expected second half of the year Medicaid contract losses, the analyst tells investors in a research note.